Rising Demand For Minimally Invasive Care Will Expand Med Tech
AN
AnalystConsensusTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
30 May 25
Updated
24 Jul 25
AnalystConsensusTarget's Fair Value
US$19.00
54.9% undervalued intrinsic discount24 Jul
US$8.56
1Y
14.4%7D
-6.1%